<DOC>
	<DOCNO>NCT01488929</DOCNO>
	<brief_summary>Negative symptom cognitive dysfunction schizophrenia ( CDS ) core feature schizophrenia . These negative symptom cognitive deficit devastate impact function , employment , social interaction patient schizophrenia . Medications use treat schizophrenia ( e.g . atypical antipsychotic ) improve negative symptom CDS . TC-5619 develop use add-on therapy combination atypical antipsychotic treat patient negative symptoms CDS .</brief_summary>
	<brief_title>Efficacy , Safety , Tolerability TC-5619 Augmentation Therapy Improve Negative Symptoms Cognition Outpatients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>1 . Diagnosis schizophrenia , per DSMIVTR criterion , aid MINI International Neuropsychiatric Interview 2 . Controlled schizophrenia , stable dose approve atypical antipsychotic least 2 month prior screen . Approved refers regulatory approval country use . 3 . Stable schizophrenia document lack psychiatric hospitalization 2 month prior Screening ( social admission convenience subject allow ) 4 . Clinical history stable psychotic symptom 1 month prior Screening . 5 . Stable positive symptom schizophrenia 4 week prior Day 1 , show score â‰¤ 4 PANSS item related delusion , hallucination , conceptual disorganization , unusual thought content , Screening Day 1 . 6 . Sum &gt; 20 7 item Negative Symptoms subscale PANSS . 7 . Calgary Depression Schizophrenia Scale ( CDSS ) score &lt; 6 . 8 . Simpson Angus Scale score &lt; 12 . 9 . Outpatient stable housing , significant presence informant group home resident . 1 . Diagnosis schizoaffective schizophreniform disorder within 1 year prior Screening . 2 . Significant risk suicide attempt suicide 12 month screen , danger others . 3 . Change dose atypical antipsychotic within 2 month Screening . 4 . Treatment electroconvulsive therapy ( ECT ) within 12 month Screening . 5 . Treatment mood stabilizer , antidepressant , anxiolytic ( shortacting hypnotic permit ) , anticholinergic , 1 antipsychotic within 1 month prior Screening . 6 . Treatment within 1 month prior Screening cognitionaffecting agent ( e.g . CNS stimulant ) . 7 . History within past 6 month screen alcohol illicit drug abuse . 8 . Use smoke cessation therapy within 1 month prior Screening . 9 . Positive urine drug screen except related prescribed shortacting benzodiazepine opiate recently prescribe episode acute pain ( e.g. , dental extraction ) . 10 . History significant major unstable neurological , neurosurgical ( e.g . head trauma ) , metabolic , hepatic , renal , hematological , pulmonary , cardiovascular , gastrointestinal , urological disorder . 11 . History myocardial infarction base medical history electrocardiogram ( ECG ) finding screen . 12 . History seizure disorder . 13 . Type 1 diabetes mellitus . 14 . Type 2 diabetes mellitus require medication ( dietcontrolled allow , HbA1C &lt; 7.3 ) . 15 . Body Mass Index ( BMI ) &gt; 35 . 16 . Uncontrolled hypothyroidism , vitamin B12 folic acid deficiency . 17 . Current TB know systemic infection ( e.g. , HBV , HCV , HIV ) . 18 . Clinically significant lab ECG abnormality could safety issue study , include QTcF &gt; 450 male &gt; 470 female . 19 . Men , woman childbearing potential , unwilling unable use accept method birth control specify Section 4.4.4 20 . Women positive pregnancy test , lactate . 21 . Participated another clinical trial within 3 month prior Screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>